Copyright
©The Author(s) 2020.
World J Gastrointest Surg. Jan 27, 2020; 12(1): 1-8
Published online Jan 27, 2020. doi: 10.4240/wjgs.v12.i1.1
Published online Jan 27, 2020. doi: 10.4240/wjgs.v12.i1.1
Surgical procedure | n (%) | |
1 | Proximal splenorenal shunt (including two interposition proximal splenorenal shunts using 10 mm Dacron graft) | 84 (72.4) |
2 | Splenoadrenal shunt | 9 (7.7) |
3 | Interposition mesocaval shunt | 5 (4.3) |
4 | Interposition first jejunal to caval shunt | 1 (0.9) |
5 | Devascularization and splenectomy | 17 (14.6) |
Total | 116 (100) |
Pathological abnormalities | Delayed presentation group, n = 67 | Early presentation group, n = 49 | P value |
Medial hypertrophy, n (%) | 67 (100) | 40 (81.6) | 0.003 |
Wall thickening, n (%) | 67 (100) | 40 (81.6) | 0.003 |
Intimal fibrosis, n (%) | 32 (47.8) | 3 (6.1) | < 0.001 |
Adventitial attenuation, n (%) | 30 (44.8) | 5 (10.2) | < 0.001 |
Thrombosis, n (%) | 32 (47.8) | 0 (0) | < 0.001 |
Vein wall calcification, n (%) | 26 (38.8) | 0 (0) | < 0.001 |
Thrombosis at anastomotic end, n (%) | 13 (19.4) | 3 (6.1) | 0.0556 |
- Citation: Gupta S, Pottakkat B, Verma SK, Kalayarasan R, Chandrasekar A S, Pillai AA. Pathological abnormalities in splenic vasculature in non-cirrhotic portal hypertension: Its relevance in the management of portal hypertension. World J Gastrointest Surg 2020; 12(1): 1-8
- URL: https://www.wjgnet.com/1948-9366/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v12.i1.1